Cargando…
Prolonged incubation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a patient on rituximab therapy
The incubation period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rarely >14 days. We report a patient with hypogammaglobulinemia who developed coronavirus disease 2019 (COVID-19) with a confirmed incubation period of at least 21 days. These findings raise concern for a pro...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578652/ https://www.ncbi.nlm.nih.gov/pubmed/33023685 http://dx.doi.org/10.1017/ice.2020.1239 |
_version_ | 1783598412975833088 |
---|---|
author | Koff, Alan G. Laurent-Rolle, Maudry Hsu, Jack Chun-Chieh Malinis, Maricar |
author_facet | Koff, Alan G. Laurent-Rolle, Maudry Hsu, Jack Chun-Chieh Malinis, Maricar |
author_sort | Koff, Alan G. |
collection | PubMed |
description | The incubation period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rarely >14 days. We report a patient with hypogammaglobulinemia who developed coronavirus disease 2019 (COVID-19) with a confirmed incubation period of at least 21 days. These findings raise concern for a prolonged presymptomatic transmission phase, necessitating a longer quarantine duration in this patient population. |
format | Online Article Text |
id | pubmed-7578652 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-75786522020-10-22 Prolonged incubation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a patient on rituximab therapy Koff, Alan G. Laurent-Rolle, Maudry Hsu, Jack Chun-Chieh Malinis, Maricar Infect Control Hosp Epidemiol Letter to the Editor The incubation period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rarely >14 days. We report a patient with hypogammaglobulinemia who developed coronavirus disease 2019 (COVID-19) with a confirmed incubation period of at least 21 days. These findings raise concern for a prolonged presymptomatic transmission phase, necessitating a longer quarantine duration in this patient population. Cambridge University Press 2020-10-07 /pmc/articles/PMC7578652/ /pubmed/33023685 http://dx.doi.org/10.1017/ice.2020.1239 Text en © The Society for Healthcare Epidemiology of America 2020 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to the Editor Koff, Alan G. Laurent-Rolle, Maudry Hsu, Jack Chun-Chieh Malinis, Maricar Prolonged incubation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a patient on rituximab therapy |
title | Prolonged incubation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a patient on rituximab therapy |
title_full | Prolonged incubation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a patient on rituximab therapy |
title_fullStr | Prolonged incubation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a patient on rituximab therapy |
title_full_unstemmed | Prolonged incubation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a patient on rituximab therapy |
title_short | Prolonged incubation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a patient on rituximab therapy |
title_sort | prolonged incubation of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) in a patient on rituximab therapy |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578652/ https://www.ncbi.nlm.nih.gov/pubmed/33023685 http://dx.doi.org/10.1017/ice.2020.1239 |
work_keys_str_mv | AT koffalang prolongedincubationofsevereacuterespiratorysyndromecoronavirus2sarscov2inapatientonrituximabtherapy AT laurentrollemaudry prolongedincubationofsevereacuterespiratorysyndromecoronavirus2sarscov2inapatientonrituximabtherapy AT hsujackchunchieh prolongedincubationofsevereacuterespiratorysyndromecoronavirus2sarscov2inapatientonrituximabtherapy AT malinismaricar prolongedincubationofsevereacuterespiratorysyndromecoronavirus2sarscov2inapatientonrituximabtherapy |